Filing Details
- Accession Number:
- 0001566028-13-000006
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-02-05 17:32:49
- Reporting Period:
- 2013-02-01
- Filing Date:
- 2013-02-05
- Accepted Time:
- 2013-02-05 17:32:49
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
887497 | Hi Tech Pharmacal Co Inc | HITK | Pharmaceutical Preparations (2834) | 112638720 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1263136 | J William Peters | C/O Hi-Tech Pharmacal Co., Inc. 369 Bayview Avenue Amityville NY 11701 | Vp And Chief Financial Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2013-02-01 | 4,603 | $10.68 | 4,603 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-01 | 4,603 | $38.00 | 0 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2013-02-05 | 36 | $10.68 | 36 | No | 4 | M | Direct | |
Common Stock | Disposition | 2013-02-05 | 36 | $38.00 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-01 | 4,603 | $0.00 | 4,603 | $10.68 |
Common Stock | Stock Option (Right to Buy) | Disposition | 2013-02-05 | 36 | $0.00 | 36 | $10.68 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
12,536 | 2009-01-29 | 2018-01-29 | No | 4 | M | Direct |
12,500 | 2009-01-29 | 2018-01-29 | No | 4 | M | Direct |
Footnotes
- The option exercises and open market sale were made pursuant to a 10b5-1 trading plan adopted by the filer in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
- Stock Option granted under Hi-Tech Pharmacal Co., Inc.'s Amended and Restated Stock Option Plan, which is a Rule 16b-3 Plan.
- The option became or becomes exercisable in four (4) equal annual installments beginning on the first anniversary of the grant date.
- Other than the option to acquire 12,500 shares reflected on this form as still held by the filer, the filer is also the holder of additional options to acquire 146,250 shares of Hi-Tech Common Stock (for aggregate options to acquire a total of 158,750 shares of Common Stock), which options were granted on various dates, with varying exercise prices and exercisable and expiration dates.